Listen Score
LS 25
Global Rank
TOP 10%

INFORMAZIONI SU QUESTO PODCAST 🔗

Conduttori:
Frequenza di aggiornamento:
every 33 days
Durata media dell'audio:
34 minutes
Interviste agli ospiti
Inglese
Stati Uniti
101 episodi
da 03 Gennaio 2019
episodic

ULTIMO EPISODIO 🔗

Stephan Jackman, CEO of Alzamend Neuro, shares his insights about leadership in biopharma and how Alzamend is working to develop effective treatments for psychiatric disorders.

CERCA TRA GLI EPISODI PASSATI

Cerca gli episodi passati di BioBoss.

EPISODI PRECEDENTI

Ryan Beal, CEO of Dyve Biosciences, shares his insights about leadership in biopharma and how Dyve is working to deliver targeted pH modulation to treat a range of immunologic and oncologic diseases.
Haseeb Ahmad, CEO of Purespring Therapeutics, shares his insights about leadership in biopharma and how Purespring is working to help patients with kidney diseases to live fuller, healthier lives.
Lance Baldo, CEO of Beacon Therapeutics, shares his insights about leadership in biopharma and how Beacon is working to save and restore sight for people living with rare and prevalent ocular diseases.
Shaun Bagai, CEO of RenovoRX, shares his insights about leadership in biopharma and how RenovoRX is working to develop targeted oncology therapies and commercialize its FDA cleared drug delivery device.
Hyung Heon Kim, CEO of MetaVia, shares his insights about leadership in biopharma and how MetaVia is working to transform cardiometabolic disease.
David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.
Stacy Lindborg, CEO of Imunon, shares her insights about leadership in biopharma and how Imunon is working to develop medicines that harness the building blocks of life to work in harmony with the body's immune system.
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2026
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da John Simboli, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.